NasdaqGM - Delayed Quote USD

TransMedics Group, Inc. (TMDX)

122.36
+0.25
+(0.20%)
At close: May 14 at 4:00:01 PM EDT
118.00
-4.36
(-3.56%)
Pre-Market: 6:37:33 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
488,227
441,540
241,623
93,459
30,262
Cost of Revenue
197,880
179,459
87,530
28,187
9,103
Gross Profit
290,347
262,081
154,093
65,272
21,159
Operating Expense
237,829
224,585
182,820
96,709
60,587
Operating Income
52,518
37,496
-28,727
-31,437
-39,428
Net Non Operating Interest Income Expense
-14,272
-14,409
-10,791
-3,726
-3,874
Other Income Expense
11,817
12,693
12,847
-1,002
-877
Pretax Income
50,063
35,780
-26,671
-36,165
-44,179
Tax Provision
1,114
316
-1,643
66
36
Net Income Common Stockholders
48,949
35,464
-25,028
-36,231
-44,215
Diluted NI Available to Com Stockholders
48,949
35,464
-25,028
-36,231
-44,215
Basic EPS
1.46
1.07
-0.77
-1.23
-1.60
Diluted EPS
1.42
1.07
-0.77
-1.23
-1.60
Basic Average Shares
33,470.31
33,229.95
32,517.37
29,556.63
27,616.84
Diluted Average Shares
36,525.74
35,216.84
32,517.37
29,556.63
27,616.84
Total Operating Income as Reported
52,518
37,496
-28,727
-31,437
-39,428
Total Expenses
435,709
404,044
270,350
124,896
69,690
Net Income from Continuing & Discontinued Operation
48,949
35,464
-25,028
-36,231
-44,215
Normalized Income
48,949
35,464
-25,028
-36,231
-44,215
Interest Income
--
--
12,500
900
-877
Interest Expense
14,272
14,409
10,791
3,726
3,874
Net Interest Income
-14,272
-14,409
-10,791
-3,726
-3,874
EBIT
64,335
50,189
-15,880
-32,439
-40,305
EBITDA
85,928
69,947
-7,703
-28,961
-38,488
Reconciled Cost of Revenue
197,880
179,459
87,530
28,187
9,103
Reconciled Depreciation
21,593
19,758
8,177
3,478
1,817
Net Income from Continuing Operation Net Minority Interest
48,949
35,464
-25,028
-36,231
-44,215
Total Unusual Items Excluding Goodwill
--
--
300
-1,900
0
Total Unusual Items
--
--
300
-1,900
0
Normalized EBITDA
85,928
69,947
-7,703
-28,961
-38,488
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/2/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PODD Insulet Corporation
321.41
+2.21%
 
QDEL QuidelOrtho Corporation
33.55
-5.52%
 
GMED Globus Medical, Inc.
58.17
-0.14%
 
CLPT ClearPoint Neuro, Inc.
12.43
-12.46%
 
QSI Quantum-Si incorporated
1.5200
+4.11%
 
SMLR Semler Scientific, Inc.
32.54
-11.34%
 
DXCM DexCom, Inc.
86.52
+2.87%
 
ALUR Allurion Technologies Inc.
2.9200
+23.73%
 
ABT Abbott Laboratories
128.56
-0.38%
 
PEN Penumbra, Inc.
288.97
-2.39%